Skip to main content

José Raul Herance Camacho

Institutions of which they are part

Head of group
Molecular Imaging and Therapy
Vall Hebron Institut de Recerca

José Raul Herance Camacho

Institutions of which they are part

Head of group
Molecular Imaging and Therapy
Vall Hebron Institut de Recerca

Projects

Administración tópica ocular de inhibidores de DPP-4: una nueva estrategia terapéutica para la retinopatía diabética

IP: Cristina Hernández Pascual
Collaborators: J. Bruno Montoro Ronsano, Ana Boixadera Espax, José Raul Herance Camacho, Lorena Ramos Pérez
Funding agency: Instituto de Salud Carlos III
Funding: 119900
Reference: DTS18/00163
Duration: 01/01/2019 - 30/06/2021

Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies

IP: José Raul Herance Camacho
Collaborators: Carolina Aparicio Gomez, Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies, Emily Betancourt Fernández, Jana Vidal Otero, Cristina Gamez Cenzano
Funding agency: The Innovative Medicines Initiative
Funding: 514560
Reference: IMMUNE-IMAGE_IMI22018
Duration: 01/10/2019 - 31/03/2026

Pendent

IP: José Raul Herance Camacho
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 91125
Reference: CPII18/00035
Duration: 08/04/2019 - 07/04/2022

Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia

IP: Rafael Simó Canonge
Collaborators: Marina Jimenez Iglesias, Cristina Hernández Pascual, Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of d, Patricia Bogdanov Baruj, Andreea Ciudin Mihai, Ferran Casals Riera, Itziar Busquets Saez, Maddalen Zufiaurre Seijo, Enrique Franky Vargas, José Raul Herance Camacho, Ingrid Balcells Ortega, Marco Inzitari
Funding agency: EUROPEAN COMMISSION
Funding: 974782.7
Reference: RECOGNISED_H2020SC1BHC2019
Duration: 01/01/2020 - 31/12/2024

Related news

ImmunoPET enables in vivo detection of LIF expression, a molecule linked to tumour growth, immune evasion and treatment resistance.

UNCAN-Connect aims to enhance interoperability and accelerate scientific progress by supporting open science and strengthening collaborations.

The second edition of the AI ​​Day served to share knowledge, reflect and chart the future of artificial intelligence applied to research and health.

Related professionals

Tayná Marques Torres Barboza

Tayná Marques Torres Barboza

Research technician
Infectious Diseases
Read more
Ma Isabel Rochera Villach

Ma Isabel Rochera Villach

Donation and transplantation of organs, tissues and cells
Read more
Valeria Tubita

Valeria Tubita

Main researcher
Biomedical Research in Gynaecology
Read more
Montserrat García Portabella

Montserrat García Portabella

Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.